|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 9/00 | |
| A61K 38/22 | |||
| A61K 47/20 | |||
| A61K 9/19 | |||
| A61K 9/14 | |||
| A61K 38/28 |
| (11) | Number of the document | 2773331 |
| (13) | Kind of document | T |
| (96) | European patent application number | 12798470.6 |
| Date of filing the European patent application | 2012-10-31 | |
| (97) | Date of publication of the European application | 2014-09-10 |
| (45) | Date of publication and mention of the grant of the patent | 2016-02-10 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2012/062816 |
| Date | 2012-10-31 |
| (87) | Number | WO 2013/067022 |
| Date | 2013-05-10 |
| (30) | Number | Date | Country code |
| 201161553388 P | 2011-10-31 | US | |
| 201261609123 P | 2012-03-09 | US |
| (72) |
PRESTRELSKI, Steven, US
SCOTT, Nancy, US
|
| (73) |
Xeris Pharmaceuticals, Inc.,
3208 Red River, Suite 300, Austin TX 78705,
US
|
| (54) | FORMULATIONS FOR THE TREATMENT OF DIABETES |
| FORMULATIONS FOR THE TREATMENT OF DIABETES |